Agarwal, N., Gebrael, G., Swami, U., Krishna, V., Krishna, V., Neema, A., Tarsode, A., Subhash, V., Sirohi, D., Borno, H., Watson, D., Sonawane, S. S., Abuzeid, W., Nimgaonkar, V., Kiedrowski, L. A., Royce, T., Joshi, A., Davis, I. D., Sweeney, C. (2026). Development and validation of computational histology artificial intelligence (CHAI)–powered prognostic and predictive biomarkers in metastatic hormone-sensitive prostate cancer (mHSPC) using ENZAMET and CHAARTED prospective randomized phase 3 trials (RCT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.231